Hindustan Agrigenetics Limited has announced the resignation of its Chief Financial Officer Ms. Chandani Kapur, effective from December 16, 2025. The company communicated this development to BSE Limited on December 17, 2025, in accordance with regulatory disclosure requirements.

Key Details of the Resignation

Ms. Kapur served as both CFO and Key Managerial Personnel of the company before tendering her resignation.

Regulatory Compliance

The announcement was made pursuant to Regulation 30 read with Para A of Part A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company has provided all detailed disclosures as required under the amended regulations and SEBI master circular dated November 11, 2024.

Hindustan Agrigenetics Limited also submitted the formal resignation notice received from Ms. Chandani Kapur along with the regulatory disclosure.

Company Information

The disclosure was signed by Mr. Rajendra Naniwadekar, Managing Director of Hindustan Agrigenetics Limited (DIN: 00032107). The company's registered office is at C-1/5, Second Floor, Safdarjung Development Area, Hauz Khas, New Delhi-110016, with correspondence address at C63, South Extension Part-II, New Delhi 110049.

The resignation represents a change in the company's key managerial structure, with the departure taking effect from the close of business hours on December 16, 2025.

Hindustan Agrigenetics Limited (ISIN: INE092301014) has reported a significant turnaround in its financial performance for the second quarter ended September 30, 2025. The company's board approved the unaudited financial results in a meeting held on November 14, 2025.

Key Financial Highlights

Revenue Growth and Profitability

Hindustan Agrigenetics has demonstrated a remarkable improvement in its financial performance. The company's total revenue surged to Rs 32.13 lacs in Q2 FY2026, a substantial increase from Rs 8.09 lacs in the previous quarter. This represents a growth of 297.20% quarter-on-quarter.

Turnaround in Profitability

The most notable aspect of the results is the company's shift from loss to profit. Hindustan Agrigenetics reported a profit after tax of Rs 16.85 lacs for Q2 FY2026, compared to a loss of Rs 40.19 lacs in the previous quarter. This turnaround indicates a significant improvement in the company's operational efficiency and market performance.

Improved Liquidity Position

The company's cash and cash equivalents increased to Rs 5,38,13,854 from Rs 5,14,05,088, showing a 4.70% improvement in its liquidity position. This enhancement in cash reserves provides the company with more financial flexibility for future operations and investments.

Corporate Governance Compliance

Hindustan Agrigenetics, in its LODR filing, stated that the provisions of Corporate Governance under SEBI regulations are not applicable to the company. This is because the company's paid-up capital does not exceed Rs. 10 Crore, and its Net Worth does not exceed Rs. 25 Crore based on the audited financial statements as of March 31, 2025.

Conclusion

The Q2 FY2026 results mark a positive shift for Hindustan Agrigenetics Limited, with significant improvements in revenue and profitability. The company has successfully turned its operations around, moving from a loss-making position to profitability within a quarter. While these results are encouraging, investors and stakeholders should continue to monitor the company's performance in the coming quarters to assess the sustainability of this growth trajectory.

The financial results were reviewed by Anant Rao & Mallik, Chartered Accountants, who found no material misstatements in the unaudited financial results prepared in accordance with applicable Indian Accounting Standards.